Saudi Arabia signed an agreement with Houston-based Celltex Therapeutics Corporation, A&M for a multi-year research study on investigating therapies for Alzheimer's, the company said in a statement on Tuesday.
The investment will support research at A&M and is part of Saudi Arabia's National Industrial Development and Logistic Program (NILDP), it further added.
Comments
{{DisplayName}}
{{ElapsedTime}}